ARMISTICE CAPITAL, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (RMTI)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol: RMTI
Shares outstanding: 89,116,466 shares
Disclosed Ownership: 8,876,000 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 15 Aug 2025, 12:30:14 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	10%	8,876,000	0	8,876,000	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	10%	8,876,000	0	8,876,000	/s/ Steven Boyd	Steven Boyd